Results 1 to 10 of about 256,433 (249)

Detection of Left Ventricular Systolic Dysfunction From Electrocardiographic Images

Circulation, 2022
BACKGROUND: Left ventricular (LV) systolic dysfunction is associated with a >8-fold increased risk of heart failure and a 2-fold risk of premature death. The use of ECG signals in screening for LV systolic dysfunction is limited by their availability to clinicians.
Veer Sangha, Arash A. Nargesi, Lovedeep S. Dhingra, Akshay Khunte, Bobak J. Mortazavi, Antônio H. Ribeiro, Evgeniya Banina, Oluwaseun Adeola, Nadish Garg, Cynthia A. Brandt, Edward J. Miller, Antonio Luiz P. Ribeiro, Eric J. Velazquez, Luana Giatti, Sandhi M. Barreto, Murilo Foppa, Neal Yuan, David Ouyang, Harlan M. Krumholz, Rohan Khera   +19 more
openaire   +5 more sources

Subclinical Left Ventricular Systolic Dysfunction in Patients with Septic Shock Based on Sepsis-3 Definition: A Speckle-Tracking Echocardiography Study

Critical Care Research and Practice, 2020
Introduction. Left ventricular dysfunction is quite common in septic shock. Speckle-tracking echocardiography (STE) is a novel, highly sensitive method for assessing left ventricular function, capable of detecting subclinical myocardial dysfunction ...
Pham Dang Hai, Le Lan Phuong, Nguyen Manh Dung, Le Thi Viet Hoa, Do Van Quyen, Nguyen Xuan Chinh, Vu Duy Minh, Pham Nguyen Son   +7 more
doaj   +2 more sources

Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction [PDF]

Circulation, 2020
Background: The term “end stage” has been used to describe hypertrophic cardiomyopathy (HCM) with left ventricular systolic dysfunction (LVSD), defined as occurring when left ventricular ejection fraction is <50%. The prognosis of HCM-LVSD has reportedly been poor, but because of its relative rarity, the natural history ...
Marstrand, Peter, Han, Larry, Day, Sharlene M, Olivotto, Iacopo, Ashley, Euan A, Michels, Michelle, Pereira, Alexandre C, Wittekind, Samuel G, Helms, Adam, Saberi, Sara, Jacoby, Daniel, Ware, James S, Colan, Steven D, Semsarian, Christopher, Ingles, Jodie, Lakdawala, Neal K, Ho, Carolyn Y   +16 more
openaire   +6 more sources

Left Ventricular Systolic Dysfunction among Hypertensive Subjects [PDF]

Journal of Clinical and Diagnostic Research, 2018
Introduction: Hypertension has been established as one of the most significant causes of heart failure. Left ventricular function is a useful measure in the assessment and prognostication of heart disease.
Anugya Aparajita Behera, Suresh Kumar Behera, Dipti Mohapatra, Arati Mohanty   +3 more
doaj   +2 more sources

Myocardial strain to detect subtle left ventricular systolic dysfunction [PDF]

European Journal of Heart Failure, 2016
In daily clinical practice, LV systolic function is routinely assessed with the use of two‐dimensional echocardiography. Using biplane LV end‐diastolic and end‐systolic volumes, LVEF is calculated. The introduction of real‐time three‐dimensional echocardiography has improved the accuracy of echocardiographic assessment of LVEF. However, calculated LVEF
Tops, L.F., Delgado, V., Marsan, N.A., Bax, J.J.   +3 more
openaire   +4 more sources

Reversible Left Ventricular Systolic Dysfunction Secondary to Pazopanib [PDF]

Cureus, 2018
Pazopanib is a tyrosine kinase inhibitor used for the treatment of advanced renal cell carcinoma and advanced soft tissue sarcoma. We describe a case report of a patient with spindle cell sarcoma who developed severe left ventricular systolic dysfunction after starting pazopanib therapy with subsequent recovery of left ventricular ejection fraction ...
Gajjar, Kushani, Balakumaran, Kathir, Kim, Agnes S   +2 more
openaire   +3 more sources

Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction. [PDF]

JACC CardioOncol
Immune checkpoint inhibitors (ICIs) have transformed cancer treatment, but ICI myocarditis (ICI-M) remains a potentially fatal complication. The clinical implications and predictors of left ventricular ejection fraction (LVEF) 
Chen YC, Dolladille C, Rao A, Palaskas NL, Deswal A, Lehmann L, Cautela J, Courand PY, Hayek S, Zhu H, Cheng RK, Alexandre J, Baldassarre LA, Roubille F, Laufer-Perl M, Asnani A, Ederhy S, Tamura Y, Francis S, Gaughan EM, Johnson DB, Flint DL, Rainer PP, Bailly G, Ewer SM, Aras MA, Arangalage D, Cariou E, Florido R, Peretto G, Itzhaki Ben Zadok O, Akhter N, Narezkina A, Levenson JE, Liu Y, Crusz SM, Issa N, Piriou N, Leong D, Sandhu S, Turker I, Moliner P, Obeid M, Heinzerling L, Chang WT, Stewart A, Venkatesh V, Du Z, Yadavalli A, Kim D, Chandra A, Zhang KW, Power JR, Moslehi J, Salem JE, Zaha VG, International ICI Myocarditis Registry.   +56 more
europepmc   +4 more sources

Contribution of serum FGF21 level to the identification of left ventricular systolic dysfunction and cardiac death

Cardiovascular Diabetology, 2017
Aim The relationship between fibroblast growth factor 21 (FGF21) and cardiovascular disease has been well established in recent studies. This study aimed to investigate the relationship between FGF21 and left ventricular systolic dysfunction and cardiac ...
Yun Shen, Xueli Zhang, Xiaoping Pan, Yiting Xu, Qin Xiong, Zhigang Lu, Xiaojing Ma, Yuqian Bao, Weiping Jia   +8 more
doaj   +2 more sources

Ross procedure in patients with severe left ventricular systolic dysfunction

Патология кровообращения и кардиохирургия, 2015
The Ross procedure outcomes in patients with left ventricular dysfunction are presented. 20 Ross procedures were performed in patients with aortic disease complicated by severe left ventricular dysfunction.
А. М. Караськов, И. И. Демин, С. И. Железнев, А. В. Богачев-прокофьев, Р. М. Шарифулин, О. И. Кулумбегов, Е. Е. Литасова, А. Б. Опен   +7 more
doaj   +3 more sources

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

The Lancet, 2008
Kim Fox, Ian Ford, Philippe Gabríel Steg, Michał Tendera, Roberto Ferrari   +4 more
openalex   +3 more sources